In this article, we will take a look at the 10 Best Robotics Stocks to Buy According to Billionaires.
Robotics Market Outlook
The robotics industry has grown modestly over the past few years. Robotic companies are growing faster than ever, driven by advancements in technology since the emergence of AI. Especially, humanoid robots are rapidly growing in the global market, driven by AI. According to Goldman Sachs’ research, the total addressable market for humanoid robots is projected to cross $38 billion by 2035, a massive upgrade from its previous forecast of $6 billion in 2023.
READ ALSO: 10 Cheap Robotics Stocks To Invest In Now.
Morgan Stanley expects the humanoid robot units to reach 40,000 by 2030 and cross 63 million by 2050. Citigroup is even more bullish, anticipating a $7 trillion humanoid robot market by 2050, with 1.19 billion humanoid robots in operation. Adam Jonas from Morgan Stanley expects humanoid robots to be a multi-decade, trillion-dollar opportunity as the adoption could accelerate faster for autonomous vehicles.
In 2023, the new World Robotics report noted around 4.28 million units operating in factories globally, growing by 10% compared to 2022. Annual installations surpassed half a million units for the third consecutive year. Asia remains the hot region for robots, with 70% of all newly deployed robots in 2023 installed in Asia. China, Japan, South Korea, and India are some of the largest robotics markets in the world. China leads the market, recording 276,288 industrial robots installed in 2023, representing 51% of the global installations. The U.S. has the largest robotics market in the region, accounting for 68% of installations in the Americas in 2023.
The U.S. stock market has been under pressure due to tariffs as the broader market has plunged over 4.50% year-to-date. At the same time, Global X Robotics & Artificial Intelligence ETF (BOTZ) and Robo Global Robotics and Automation Index ETF (ROBO), which returned over 11% in 2024, have dropped nearly 10% and 7% year-to-date, respectively. Despite the market facing political headwinds, robotics stocks hold great promise, considering the rising demand for humanoids and automation systems.
With that said, let’s take a look at the 10 Best Robotics Stocks to Buy According to Billionaires.
A technician adjusting a human-machine interface in a laboratory surrounded by indoor multi-terrain robots.
Our Methodology
To compile our list of the best robotics stocks to buy according to billionaires, we looked for the robotics and automation companies widely held by billionaires. Data for the billionaire holders for each stock was taken from Insider Monkey’s database, updated as of Q4 2024. Finally, the 10 best robotics stocks to buy were ranked in ascending order based on the billionaire investors holding stakes in them. We have also mentioned the number of hedge funds holding each stock as of Q4 2024.
Why are we interested in the stocks that hedge funds and billionaire investors pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
10 Best Robotics Stocks To Buy According to Billionaires
10. UiPath Inc. (NYSE:PATH)
No. of Billionaire Investors: 8
No. of Hedge Fund Holders: 40
UiPath Inc. (NYSE:PATH) offers enterprise automation and AI software services. It is mainly engaged in building and managing automation and developing computer vision technology. UiPath’s robotic process automation (RPA) helps to build, deploy, and manage software robots that imitate human actions. UiPath recently released a free 60-day trial of its FedRAMP-compliant Automation Cloud Public Sector solution for U.S. government agencies. The platform brings tools such as mining, robots, low-code apps, and AI-powered document understanding. These tools enhance efficiency and data security for the agencies.
On March 26, RBC Capital analyst Matthew Hedberg reiterated a Sector Perform rating on PATH stock, keeping a price target of $13. The analyst sees UiPath’s potential in emerging AI and agentic technology. UiPath Inc. (NYSE:PATH) ended the year with a revenue of $424 million for Q4 FY2025, posting an ARR of $1.67 billion. The company experienced solid adoption of its AI products, with an attach rate of almost 20% of total customers. UiPath’s Agentic platform made notable progress, driven by strong customer engagement and nearly 3,000 agents created for mission-critical processes. The company ended the FY2025 with a solid balance sheet, holding approximately $1.7 billion in cash and cash equivalents.
9. Oceaneering International, Inc. (NYSE:OII)
No. of Billionaire Investors: 10
No. of Hedge Fund Holders: 31
Oceaneering International, Inc. (NYSE:OII) is a leading technology company delivering engineered services and products and robotic solutions to the offshore energy, defense, aerospace, and manufacturing industries worldwide. It provides remotely operated vehicles (ROVs) for drill support and vessel-based services. The company operates through the Subsea Robotics, Manufactured Products, Offshore Projects Group, Integrity Management & Digital Solutions, and Aerospace and Defense Technologies segments.
On March 5, Barclays analyst David Anderson downgraded the price target on OII from $26 to $22. The analyst has kept an Equal-Weight rating on the shares following another solid year for the company. Oceaneering International, Inc. (NYSE:OII) posted mixed results for 2024, surpassing revenue and missing the earnings estimate by a slight margin. The company posted a revenue of $2.66 billion in 2024, beating the estimates by $31.96 million. The earnings came short of the consensus of $1.31, reaching $1.14 per share.
Oceaneering International saw a notable order intake of $2.9 billion last year, indicating strong customer confidence. The company achieved its highest quarterly revenue in the fourth quarter since Q4 of 2025 and exceeded $100 million in adjusted EBITDA for the first time since Q2 of 2016. Oceaneering’s Subsea Robotics (SSR) segment experienced a 361 basis point improvement in EBITDA margin from a year ago, ending the year at 36%. In addition, the company continues to improve its operational safety, achieving a 56% reduction in high-potential incidents in 2024.
8. PROCEPT BioRobotics Corporation (NASDAQ:PRCT)
No. of Billionaire Investors: 10
No. of Hedge Fund Holders: 27
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is a commercial-stage company specializing in surgical robotics solutions for urology. The AquaBeam Robotic System is PROCEPT’s flagship product with an advanced image-guided system designed for minimally-invasive urologic surgeries.
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is heading in the right direction with a strong end to 2024. The company achieved a 65% year-over-year growth in revenue, posting $224.5 million. The company’s robot sales and procedures are attracting customers, especially in the U.S. The company achieved a 60% growth in the U.S. installed base, with 505 systems by the end of the year. Moreover, the company’s international revenue also spiked over 137% during Q4, driven by strong sales momentum in the U.K. In Q4, the gross margin reached an all-time high of 64%, thanks to improved operational efficiencies and higher average selling prices. The average selling price of PROCEPT’s systems was approximately $460,000 in 2024.
PROCEPT BioRobotics Corporation’s Hydro robotic system has been well-received, leading to a robust capital pipeline. The Hydro robotic system features advanced AI and ultrasound integration. With positive product developments and improved sales, the company expects its 2025 revenue to be around $320 million, a 43% increase compared to 2024.
7. Zebra Technologies Corporation (NASDAQ:ZBRA)
No. of Billionaire Investors: 11
No. of Hedge Fund Holders: 45
Zebra Technologies Corporation (NASDAQ:ZBRA) has emerged as one of the top robotics companies. It is engaged in the Automatic Identification and Data Capture (AIDC) industry. The company assists organizations to monitor, anticipate, and accelerate workflows by empowering their frontline and ensuring that everything is connected and fully optimized. The company operates globally in industries including retail, manufacturing, transportation and logistics, and healthcare. Zebra operates in more than 100 countries, and its customers include over 80% of the Fortune 500 companies.
Zebra Technologies Corporation acquired Fetch Robotics for $290 million in 2021, and since then, it has been aggressively expanding its presence in the robotics industry. Recently, the company acquired Photoneo, a market leader in the 3D machine vision solutions industry. Photoneo is a well-known developer of robotic vision and intelligence solutions. This acquisition adds to Zebra’s high-value 3D machine vision use cases for clients in automotive manufacturing, logistics, and other key industries.
Zebra Technologies Corporation (NASDAQ:ZBRA) had a solid end to 2024, with a 32% year-over-year increase in sales for Q4, surpassing $1.3 billion. For the full year, the company achieved a revenue of $4.68 billion, exceeding the estimated $4.96 billion. The company saw strong double-digit sales growth across all regions, especially in the Americas. Zebra Technologies made notable developments in diversifying its supply chain, minimizing its reliance on China, and mitigating tariff impacts.
6. Teradyne, Inc. (NASDAQ:TER)
No. of Billionaire Investors: 11
No. of Hedge Fund Holders: 61
Teradyne, Inc. (NASDAQ:TER) is a technology company that designs, develops, and manufactures automated test equipment and advanced robotics systems. Teradyne’s core focus remains on semiconductor testing and industrial automation technologies. Its ATE solutions ensure the quality and performance of AI chips, which have complex architectures and require advanced testing.
Teradyne recently announced a definitive agreement to acquire Quantifi Photonics, a photonic IC testing company. This deal will enhance Teradyne’s ability to deliver scalable photonic integrated circuit test solutions. Earlier in January, the company partnered with Infineon Technologies to improve power semiconductor testing, acquiring part of Infineon’s automated test equipment team in Germany. Teradyne, Inc. (NASDAQ:TER) has also revealed its latest AI-driven robotics solutions at the NVIDIA GTC 2025. The AI toolkit developed with NVIDIA marks the first public demonstration of the AI Accelerator in commercially viable applications.
AI accelerators are becoming a key part of Teradyne’s strategic growth. In 2024, the company achieved a 17% year-over-year growth in SOC and memory test revenue, driven by AI accelerator ASICs, networking, and HBM DRAM.
5. Rockwell Automation, Inc. (NYSE:ROK)
No. of Billionaire Investors: 11
No. of Hedge Fund Holders: 39
Rockwell Automation, Inc. (NYSE:ROK) is engaged in industrial automation and digital transformation. It operates in more than 100 countries across the globe. Allen-Bradley, FactoryTalk software, and LifecycleIQ Services are some of the well-known brands of Rockwell. The company operates in three segments: Intelligent Devices, Software & Control, and Lifecycle Services. Rockwell industrial automation and information solutions are key for setting and integrating robotic systems in manufacturing and other industrial setups. For instance, Rockwell’s programmable logic controllers (PLCs) are important for the accurate and coordinated movement of robotic systems.
On March 26, Julian Mitchell from Barclays lowered ROK’s price target from $285 to $280, maintaining an Equal-Weight on the stock. The analyst retains the rating after dropping the price target twice in March. Mitchell has adjusted targets in the multi-industry group as part of a Q1 preview. The analyst expects revenue and margin pressure alongside lower investor expectations. However, Mitchell underscores a potential correlation between Rockwell’s sales performance and the political environment, especially considering the historical context of the company’s sales boost following the 2016 elections.
Madison Dividend Income Fund stated the following regarding Rockwell Automation, Inc. (NYSE:ROK) in its Q4 2024 investor letter:
“This quarter we want to highlight two new relative yield investments made during the quarter. The Fund purchased Rockwell Automation, Inc. (NYSE:ROK) as a new Industrial holding. ROK is a high-quality global industrial automation equipment and services company. We believe it has a sustainable competitive advantage due to its large installed base of mission-critical automation equipment, high customer switching costs, strong brand reputation, and intangible assets.
ROK experienced a cyclical downturn in orders, revenues, and earnings in 2024 that created an opportunity to purchase stock at an attractive valuation. As shown in the graph below, ROK had a relative dividend yield of 1.4x the S&P 500 at the time of purchase, which was its highest relative yield since the 2008-2009 financial crisis. Company orders appear set to trough throughout 2025 and long-term demand for automation products should grow faster than GDP, driven by favorable secular trends including U.S. reshoring and supply chain de-risking. ROK has an A-rated balance sheet by Standard & Poor’s and has raised its dividend by an average of 5% over the past five years. We expect continued dividend increases going forward.”
4. Stryker Corporation (NYSE:SYK)
No. of Billionaire Investors: 13
No. of Hedge Fund Holders: 70
Stryker Corporation (NYSE:SYK) is a medical technology company that offers products and services in Medical and Surgical, Neurotechnology, Orthopedics, and Spine. Its robotics arm, Mako, develops spinal and knee devices, among other products. Stryker also specializes in soft tissue fixation products and delivering AI-assisted virtual care workflows. The company assists surgeons in visualizing and reviewing patients via Apple Vision Pro.
On March 21, Needham analyst Mike Matson reiterated a Buy rating on SYK shares, with a price target of $442. Matson retains a positive view of SYK shares following the acquisition of Inari Medical, a company that provides innovative solutions for venous thromboembolism (VTE) clot removal without the use of thrombolytic drugs. Matson has raised FY25 and FY26 revenue estimates for Stryker, driven by Inari Medical’s revenue streams. Moreover, Stryker continues to experience solid demand for its Mako robotic-assisted surgery systems, with record installations in the U.S. and worldwide. The company posted a strong sales growth of 10% year-over-year in 2024. Whereas the adjusted earnings per share increased by 15% from a year ago. Stryker expects an organic sales growth of 8% to 9% in 2025.
3. RTX Corporation (NYSE:RTX)
No. of Billionaire Investors: 17
No. of Hedge Fund Holders: 80
RTX Corporation (NYSE:RTX) is a leading aerospace and defense company that offers drone-based missile systems and counter-drone technologies. Its flagship military robot, Coyote, is a drone used to track and shoot down enemy UAVs. The company provides different advanced systems and services for commercial, military, and government customers globally. RTX operates its services and products through three businesses, including Collins Aerospace, Pratt & Whitney, and Raytheon. RTX remains a key player in the military drone market and also remains a major manufacturer of radars, sensors, and electronic warfare equipment.
On March 19, Baird analyst Peter Arment upgraded the rating on RTX shares from Neutral to Outperform, raising the price target from $136 to $160. The analyst believes that the multi-year Department of Defense replenishment cycle and rising European defense orders amid NATO rearmament will play a positive role in RTX’s growth. President Trump’s call for NATO members to increase defense spending to 5% of GDP from around 2% and the European Union’s proposed €800 billion ReArm Europe plan are considered to be catalysts for RTX going forward.
Longleaf Partners Fund stated the following regarding RTX Corporation (NYSE:RTX) in its Q4 2024 investor letter:
“RTX Corporation (NYSE:RTX) – Aerospace and defense company RTX was a top contributor for the year. Our appraisal value has grown nicely since we first purchased the company just over a year ago. While the issues for Pratt & Whitney’s (P&W) Geared Turbofan engine are still not yet fully fixed, they have gotten better and given us another reminder that the point of maximum pessimism is only obvious in retrospect. We continue to have a conservative valuation on P&W so view this as a source of future value upside. The Raytheon segment has also performed better as the year has gone on, with recent signs of margin improvement. Strong industry tailwinds, prudent capital allocation, and a solid balance sheet provide a foundation for sustained growth and eventual full value recognition.”
2. Intuitive Surgical, Inc. (NASDAQ:ISRG)
No. of Billionaire Investors: 18
No. of Hedge Fund Holders: 95
Intuitive Surgical, Inc. (NASDAQ:ISRG) is a pioneer in robotic-assisted surgery, famously known for its da Vinci Surgical System. The company’s advanced robotics assist minimally invasive procedures, improving surgical precision and patient outcomes. The company has a strong global presence, with its technology widely adopted in hospitals and surgical centers.
Over the years, Intuitive Surgical, Inc. (NASDAQ:ISRG) has expanded beyond the da Vinci system. In 2019, the company launched Ion Robotic Bronchoscopy, which is used in oncology to conduct minimally invasive lung biopsies. In 2024, Ion’s installed base grew by 51% to more than 800 systems. Intuitive Surgical has also released Intuitive Hub, a technology platform that automatically records videos for review and collaboration during surgeries.
On March 18, Baird analyst David Rescott downgraded the price target of ISRG shares from $707 to $600, maintaining an Outperform rating on the shares. Rescott lowered the price target following the change in the company’s model and believes the tariff impact is already priced into the shares. The analyst also notes that the company has several levers to neutralize the headwinds. On the other side, Wells Fargo analyst Larry Biegelsen reiterated a Buy rating on the stock with a price target of $687. Biegelsen was optimistic based on Intuitive Surgical’s recent FDA 510(k) clearance for its SP stapler, which is expected to boost adoption of the SP platform in the U.S. This approval is important for thoracic and colorectal procedures, where Intuitive Surgical projects increased commercial activity.
1. Tesla, Inc. (NASDAQ:TSLA)
No. of Billionaire Investors: 21
No. of Hedge Fund Holders: 126
Tesla, Inc. (NASDAQ:TSLA) is one of the world’s leading manufacturers of electric vehicles (EVs). However, investors are more focused on its products, such as its full self-driving software (FSD), Cybercab robotaxi, and Optimus robot, which could each be trillion-dollar platforms in the future.
Tesla, Inc. (NASDAQ:TSLA) has suffered a drop of 1% year-over-year in deliveries in FY2024. In 2024, Cathie Wood’s Ark Invest Management projected TSLA shares to surge to $2,600 by 2029 based on products like FSD and the Cybercab. Ark’s financial models suggest that Tesla’s EV sales will only represent 26% of the company’s revenue by 2029, with autonomous ride-hailing making up the majority instead. Tesla’s Cybercab is a fully autonomous robotaxi that will run entirely on its FSD software.
On March 21, Wedbush analyst Daniel Ives reiterated an Outperform rating on TSLA shares, keeping a price target of $550. Ives is bullish on TSLA over its upcoming Cybercab, full self-driving expansion, and a lower-cost vehicle launch later this year.
“Musk did a very good job in our opinion discussing the Tesla long-term strategic vision, autonomous, robotics, and showing leadership at a time it was very needed for the Tesla story,” Wedbush analysts wrote.
While we acknowledge the potential of TSLA to grow, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than TSLA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks To Invest In According to Billionaires.
Disclosure. None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
